Cooperative in vivo cytotoxicity of ionizing radiation and the protein kinase C-inhibitor PKC412 in p53-deficient, radioresistant tumor cells

被引：1
|
作者：
Zaugg, K
Resch, H
Hegyi, I
Glanzmann, C
Fabbro, D
Bodis, S
Pruschy, M
机构：
[1] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland
[3] Novartis Pharma Inc, CH-4002 Basel, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81116-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
689
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 14 条
  • [1] Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412
    Zaugg, K
    Rocha, S
    Resch, H
    Hegyi, I
    Oehler, C
    Glanzmann, C
    Fabbro, D
    Bodis, S
    Pruschy, M
    CANCER RESEARCH, 2001, 61 (02) : 732 - 738
  • [2] PKC412, a selective inhibitor of protein kinase C, prolongs the survival time of spontaneous tumor metastatic model mouse
    Yoshikawa, N
    Nakamura, K
    Konoha, K
    Yamaguchi, Y
    Kagota, S
    Shinozuka, K
    Kunitomo, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 131P - 131P
  • [3] A Wee1 kinase inhibitor increased cytotoxicity of oncolytic adenoviruses in p53-deficient cells
    Morinaga, T.
    Thao, N. T.
    Boya, Z.
    Tagawa, M.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 256 - 256
  • [4] Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro
    Ganeshaguru, K
    Wickremasinghe, RG
    Jones, DT
    Gordon, M
    Hart, SM
    Virchis, AE
    Prentice, HG
    Hoffrand, AV
    Man, A
    Champain, K
    Csermak, K
    Mehta, AB
    HAEMATOLOGICA, 2002, 87 (02) : 167 - 176
  • [5] Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells
    Yoshikawa, N
    Nakamura, K
    Yamaguchi, Y
    Kagota, S
    Shinozuka, K
    Kunitomo, M
    LIFE SCIENCES, 2003, 72 (12) : 1377 - 1387
  • [6] ENHANCEMENT OF RADIATION RESPONSE IN P53-DEFICIENT CANCER CELLS IN VIVO USING DIFFERENT SCHEDULES OF RADIATION AND AZD1152, AN AURORA B KINASE INHIBITOR
    Tao, Y.
    Leteur, C.
    Frascogna, V.
    Zhang, P.
    Opolon, P.
    Mundt, K.
    Kroemer, G.
    Bourhis, J.
    Deutsch, E.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S42 - S42
  • [7] Enhancement of radiation response in p53-deficient cancer cells in vivo using different schedules of radiation and AZD1152, an Aurora B kinase inhibitor
    Tao, Y.
    Leteur, C.
    Frascogna, V.
    Zhang, P.
    Opolon, P.
    Mundt, K. E.
    Kroerner, G.
    Bourhis, J.
    Deutsch, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S713 - S713
  • [8] Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
    Y Tao
    P Zhang
    F Girdler
    V Frascogna
    M Castedo
    J Bourhis
    G Kroemer
    E Deutsch
    Oncogene, 2008, 27 : 3244 - 3255
  • [9] Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
    Tao, Y.
    Zhang, P.
    Girdler, F.
    Frascogna, V.
    Castedo, M.
    Bourhis, J.
    Kroemer, G.
    Deutsch, E.
    ONCOGENE, 2008, 27 (23) : 3244 - 3255
  • [10] Enhancement of radiation response by the Aurora kinase inhibitor CYC116 in Ras mutant and p53-deficient cancer cells
    Leteur, Celine
    Tao, Yungan
    Deutsch, Eric
    Bourhis, Jean
    CANCER RESEARCH, 2009, 69
12